Advertisement

Index by author

November 01, 1999; Volume 291,Issue 2

  1. Raby, Charlotte A.

    1. Milameline (CI-979/RU35926): A Muscarinic Receptor Agonist with Cognition-Activating Properties: Biochemical and In Vivo Characterization
      Roy D. Schwarz, Michael J. Callahan, Linda L. Coughenour, Melvin R. Dickerson, Jack J. Kinsora, William J. Lipinski, Charlotte A. Raby, Carolyn J. Spencer and Haile Tecle
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 812-822;

  2. Raju, Vulapali S.

    1. Spin Trap (N-t-butyl-α-phenylnitrone)-Mediated Suprainduction of Heme Oxygenase-1 in Kidney Ischemia/Reperfusion Model: Role of the Oxygenase in Protection against Oxidative Injury
      Mahin D. Maines, Vulapali S. Raju and Nariman Panahian
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 911-919;

  3. Rao, Marie Luise

    1. Pharmacokinetic-Pharmacodynamic Modeling of Tolerance to the Prolactin-Secreting Effect of Chlorprothixene after Different Modes of Drug Administration
      Metin Bagli, Richard Süverkrüp, Ralph Quadflieg, Gereon Höflich, Siegfried Kasper, Hans-Jürgen Möller, Michael Langer, Uwe Barlage and Marie Luise Rao
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 547-554;

  4. Rieman, David J.

    1. Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis
      Michael W. Lark, George B. Stroup, Shing Mei Hwang, Ian E. James, David J. Rieman, Fred H. Drake, Jeremy N. Bradbeer, Ashwini Mathur, Karl F. Erhard, Kenneth A. Newlander, Stephen T. Ross, Kevin L. Salyers, Brian R. Smith, William H. Miller, William F. Huffman and Maxine Gowen
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 612-617;

  5. Ring, Kevin M.

    1. Variability in Phenylephrine Response and Essential Hypertension: A Search for Human α1B-Adrenergic Receptor Polymorphisms
      Rainer Büscher, Volker Herrmann, Kevin M. Ring, Mala T. Kailasam, Daniel T. O’Connor, Robert J. Parmer and Paul A. Insel
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 793-798;

  6. Roby-shemkowitz, Alison

    1. Effects of Regulators of G Protein-Signaling Proteins on the Functional Response of the μ-Opioid Receptor in a Melanophore-Based Assay
      Marc N. Potenza, Stephen J. Gold, Alison Roby-Shemkowitz, Michael R. Lerner and Eric J. Nestler
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 482-491;

  7. Rodrigues, A. David

    1. Role of a Potent Inhibitory Monoclonal Antibody to Cytochrome P-450 3A4 in Assessment of Human Drug Metabolism
      Qin Mei, Cuyue Tang, Carol Assang, Yuh Lin, Donald Slaughter, A. David Rodrigues, Thomas A. Baillie, Thomas H. Rushmore and Magang Shou
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 749-759;

  8. Roerig, Sandra C.

    1. Canine Cardiac Muscarinic Receptors, G Proteins, and Adenylate Cyclase after Long-Term Morphine
      Leslie D. Napier, Sandra C. Roerig, Darice A. Yoshishige, Barbara A. Barron and James L. Caffrey
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 725-732;

  9. Ros, Jenny

    1. Effect of Molecular Charge on Intestinal Epithelial Drug Transport: pH-Dependent Transport of Cationic Drugs
      Katrin Palm, Kristina Luthman, Jenny Ros, Johan Gråsjö and Per Artursson
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 435-443;

  10. Rosenblum, Michael

    1. Safety, Pharmacokinetics, and Tissue Distribution of Liposomal P-Ethoxy Antisense Oligonucleotides Targeted to Bcl-2
      Yolanda Gutiérrez-Puente, Ana M. Tari, Clifton Stephens, Michael Rosenblum, Reyes Tamez Guerra and Gabriel Lopez-Berestein
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 865-869;
« Previous (Pages : 21 22 23 24 25 26 27 28 29 30 ... 35) Next »
Back to top

In this issue

Advertisement